NMPA Notice on the Registration Requirements for Drug–Device Combination Products
To strengthen the regulatory oversight and registration management of drug–device combination products, and in accordance...
EUROPE
1. Clarification on “first certification for that type of device” and corresponding procedures to be followed by notified bodies, in context of the consultation of the expert panel referred...